NCT00053352

Trial Number: NCT00053352 (ClinicalTrials.gov)

Disease Type:

Germ Cell Neoplasm - Extragonadal Germ Cell Cancer (excluding Gestational Trophoblastic Disease and Germ Cell Tumors of the CNS)
Germ Cell Neoplasm - Miscellaneous
Germ Cell Neoplasm - Ovarian Germ Cell Cancer
Germ Cell Neoplasm - Testicular Germ Cell Cancer

Trial Title:

A Phase III Study Of Reduced Therapy In The Treatment Of Children With Low And Intermediate Risk Extracranial Germ Cell Tumors

Study ID:

AGCT0132

Images are available?:

Is this a NCI-MATCH Trial?:

Title	Description
NCT00053352-D5	NCT00053352-D5 The dataset provides the information for baseline characteristics and event-free and overall survival for all eligible patients as well as by the different subgroups reported in the manuscript. There is one row per patient.
NCT00053352-D4	NCT00053352-D4 Adverse events. The dataset provides the information for the specific toxicities that occurred during induction and consolidation as reported in the manuscript. There are multiple rows per patient depending on whether they had multiple courses or Adverse events submitted.
NCT00053352-D3	NCT00053352-D3 Historical Control. The dataset provides the information for event-free survival for all eligible historical control patients. It contains all the characteristics needed to do the different subgroup analyses reported in the manuscript. There is one row per patient.
NCT00053352-D2	NCT00053352-D2 The dataset provides the information for baseline characteristics and event-free and overall survival for all eligible patients as well as by the different subgroups reported in the manuscript. There is one row per patient.
NCT00053352-D1	NCT00053352-D1 The dataset provides the information for the consort diagram (Figure 1). There is one row per patient.

NIH…Turning Discovery Into Health^®